Neurocrine Biosciences, Inc. (NBIX)
130.63
-1.75
(-1.32%)
USD |
NASDAQ |
Mar 03, 11:02
Neurocrine Biosciences EPS Diluted (Quarterly) : 1.482 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Glaukos Corp. | -2.324 |
| Edgewise Therapeutics, Inc. | -0.4737 |
| Nuvalent, Inc. | -1.585 |
| Marker Therapeutics, Inc. | -0.1193 |
| CapsoVision, Inc. | -0.1693 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 153.70M |
| Revenue (Quarterly) | 805.50M |
| Total Expenses (Quarterly) | 651.80M |
| Enterprise Value | 12.28B |
| Gross Profit Margin (Quarterly) | 97.82% |
| Profit Margin (Quarterly) | 19.08% |
| Earnings Yield | 3.57% |
| Operating Earnings Yield | 4.76% |
| Normalized Earnings Yield | 3.685 |